These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27828790)

  • 1. NaoXinTong Enhances Atorvastatin-induced Plaque Stability While Ameliorating Atorvastatin-induced Hepatic Inflammation.
    Yang X; Li Y; Sun L; Liu Y; Ma C; Chen Y; Tan H; Li Q; Li X; Wang Y; Duan Y; Zhao B; Han J
    J Cardiovasc Pharmacol; 2017 Jan; 69(1):55-64. PubMed ID: 27828790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NaoXinTong Inhibits the Advanced Atherosclerosis and Enhances the Plaque Stability in Apolipoprotein E Deficient Mice.
    Yang X; Sun L; Li Y; Ma C; Yang J; Zhang W; Zhao B; Jia L; Duan Y; Han J; Li X; Chen Y
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):203-11. PubMed ID: 26485209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
    Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A
    Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of co-administration of atorvastatin and endothelin-1 receptor antagonist on the progression of atherosclerosis in rabbit.
    Sun Y; Liu J; Yang B; Sai X; Li T; Wang D; Zhou R
    APMIS; 2014 Jun; 122(6):556-64. PubMed ID: 24164644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis factor-like weak inducer of apoptosis in apolipoprotein E deficient mice].
    Fernández-Laso V; Sastre C; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Clin Investig Arterioscler; 2015; 27(1):17-25. PubMed ID: 25027757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of Naoxintong capsule alone and in combination with ticagrelor and atorvastatin in rats with Qi deficiency and blood stasis syndrome.
    Zhang WJ; Su WW; Lin QW; He Y; Yan ZH; Wang YG; Li PB; Wu H; Liu H; Yao HL
    Pharm Biol; 2020 Dec; 58(1):1006-1022. PubMed ID: 32985308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol-independent effects of atorvastatin prevent cardiovascular morbidity and mortality in a mouse model of atherosclerotic plaque rupture.
    Roth L; Rombouts M; Schrijvers DM; Martinet W; De Meyer GR
    Vascul Pharmacol; 2016 May; 80():50-8. PubMed ID: 26826559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatoprotective effect of the combination use of Fructus Schisandrae with statin--A preclinical evaluation.
    Wat E; Ng CF; Wong EC; Koon CM; Lau CP; Cheung DW; Fung KP; Lau CB; Leung PC
    J Ethnopharmacol; 2016 Feb; 178():104-14. PubMed ID: 26666731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis.
    Hoeke G; Wang Y; van Dam AD; Mol IM; Gart E; Klop HG; van den Berg SM; Pieterman EH; Princen HMG; Groen AK; Rensen PCN; Berbée JFP; Boon MR
    Atherosclerosis; 2017 Dec; 267():116-126. PubMed ID: 29121499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
    Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
    J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of NaoXinTong Capsule on the developed diabetic nephropathy in db/db mice.
    Yang S; Chen Y; Duan Y; Ma C; Liu L; Li Q; Yang J; Li X; Zhao B; Wang Y; Qian K; Liu M; Zhu Y; Yang X; Han J
    Biomed Pharmacother; 2019 Oct; 118():109389. PubMed ID: 31545275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of hepatic Nogo-B receptor expression-A new anti-liver steatosis mechanism of statins.
    Zhang W; Yang X; Chen Y; Hu W; Liu L; Zhang X; Liu M; Sun L; Liu Y; Yu M; Li X; Li L; Zhu Y; Miao QR; Han J; Duan Y
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Feb; 1863(2):177-190. PubMed ID: 29217477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
    Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-treatment of Pitavastatin and Dexamethasone Exacerbates the High-fat Diet-induced Atherosclerosis in apoE-deficient Mice.
    Zhang W; Wang X; Hu W; Liu L; Li X; Han J; Chen Y; Duan Y
    J Cardiovasc Pharmacol; 2015 Aug; 66(2):189-95. PubMed ID: 25874855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-fat diet induced alteration in lipid enzymes and inflammation in cardiac and brain tissues: Assessment of the effects of Atorvastatin-loaded nanoparticles.
    Abd-Rabo MM; Wahman LF; El Hosary R; Ahmed IS
    J Biochem Mol Toxicol; 2020 May; 34(5):e22465. PubMed ID: 32048413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
    Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ
    Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rice bran enzymatic extract reduces atherosclerotic plaque development and steatosis in high-fat fed ApoE-/- mice.
    Perez-Ternero C; Claro C; Parrado J; Herrera MD; Alvarez de Sotomayor M
    Nutrition; 2017 May; 37():22-29. PubMed ID: 28359358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial.
    Kawahara T; Nishikawa M; Kawahara C; Inazu T; Sakai K; Suzuki G
    Circulation; 2013 Jun; 127(23):2327-35. PubMed ID: 23658438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naoxintong capsule remodels gut microbiota and ameliorates early-stage atherosclerosis in apolipoprotein E-deficient mice.
    Wan H; Lu Y; Yang J; Wan H; Yu L; Fang N; He Y; Li C
    Phytomedicine; 2024 Jul; 129():155662. PubMed ID: 38728917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-trans retinoic acid effectively reduces atheroma plaque size in a rabbit model of high-fat-induced atherosclerosis.
    Zarei L; Bahrami M; Farhad N; Froushani SMA; Abbasi A
    Adv Clin Exp Med; 2018 Dec; 27(12):1631-1636. PubMed ID: 30048051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.